| ￥3300 | |
| Z06082-100 | |
|
|
|
|
|
|
|
|
|
| Species | Mouse | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its ability to convert the substrate 3, 4dihydroxy Lphenylalanine (LDopa) to 3, 4dihydroxyphenylethylamine (dopamine). The dopamine product is measured by its absorbance at 340 nm after derivatization with trinitrobenzene sulfonic acid. Test result meets the standard. | ||||
| Expression System | Baculovirus-Insect Cells | ||||
| Theoretical Molecular Weight | 55.40 kDa | ||||
| Apparent Molecular Weight | The protein has a predicted MW of 55.40 kDa same as Bis-Tris PAGE result. | ||||
| Formulation | Supplied as 0.22 μm filtered solution in 20mM Tris, 0.3M NaCl, 10% Glycerol (pH 8.0). | ||||
| Concentration | Verified by one or more methods from 0.64mg/ml A280/Bioactivity/BCA/Bradford. | ||||
| Storage & Stability | This product remains stable for 6 months at -80°C or below. Avoid repeated freeze-thaw cycles. |
| Target Background | Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare genetic disorder characterized by deficient synthesis of dopamine and serotonin. It presents in early infancy, and causes severe developmental disability and lifelong motor, behavioral, and autonomic symptoms including oculogyric crises (OGC), sleep disorder, and mood disturbance. |
| Synonyms | AADC |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
